Observational study of talimogene laherparepvec use for melanoma in clinical practice in the United States (COSMUS-1)

AIM: Talimogene laherparepvec (T-VEC) is an intralesional treatment for unresectable cutaneous, subcutaneous and nodal melanoma. COSMUS-1 was conducted to examine how T-VEC is used in US clinical practice. MATERIALS & METHODS: A chart review was conducted at seven centers, with 78 patients scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, Matthew C, Zager, Jonathan S, Amatruda, Thomas, Conry, Robert, Ariyan, Charlotte, Desai, Anupam, Kirkwood, John M, Treichel, Sheryl, Cohan, David, Raskin, Leon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2019
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688558/
https://www.ncbi.nlm.nih.gov/pubmed/31406563
http://dx.doi.org/10.2217/mmt-2019-0012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688558/
https://www.ncbi.nlm.nih.gov/pubmed/31406563
http://dx.doi.org/10.2217/mmt-2019-0012

Ejemplares similares